Evaluation of Artemisia amygdalina D. for Anti-Inflammatory and Immunomodulatory Potential

Table 1

Effect of different extracts of Artemisia amygdalina D. on Carrageenin-induced paw edema in rats (mean ± SE) (𝑛=4).

S. no.	Groups	Dose (mg/kg)	Initial paw vol. (mL)	Paw vol. after 4 h (mL)	Edema (4 h)	% age inhibition (4 h)
1	Control	NS	0.95 ± 0.03	1.9 ± 0.04	0.95 ± 0.03^a	—
2	AMT	250	1 ± 0.00	1.52 ± 0.05	0.52 ± 0.05^b	45.26
3	AET	250	0.97 ± 0.05	1.75 ± 0.06	0.77 ± 0.05^b	18.95
4	APT	250	0.95 ± 0.04	1.87 ± 0.09	0.92 ± 0.07^ac	3.16
5	AAQ	250	0.92 ± 0.02	1.6 ± 0.04	0.67 ± 0.05^bc	29.47
6	Diclo	20	1.07 ± 0.07	1.52 ± 0.05	0.45 ± 0.03^c	52.63

Values along the same column with different superscripts are statistically significant to each other using Tukey’s HSD test (𝑃<0.05). AMT: methanolic extract; AET: ethyl acetate extract; APT: petroleum ether extract; AAQ: aqueous extract; Diclo: diclofenac.